Tsianakas, A
170  Ergebnisse:
Personensuche X
?
1

Acceptability and perceived benefits of validated pruritus ..:

Pereira, M. P. ; Zeidler, C. ; Szymczak, H....
Journal of the European Academy of Dermatology and Venereology.  , 2024
 
?
4

Secukinumab demonstrates high efficacy and a favourable saf..:

Bodemer, C. ; Kaszuba, A. ; Kingo, K....
Journal of the European Academy of Dermatology and Venereology.  35 (2021)  4 - p. 938-947 , 2021
 
?
 
?
6

Effets du dupilumab sur les résultats du SCORAD dans la der..:

Wollenberg, A. ; Szepietowski, J.C. ; Tsianakas, A....
Annales de Dermatologie et de Vénéréologie.  146 (2019)  12 - p. A339 , 2019
 
?
7

Secukinumab dosing optimization in patients with moderate‐t..:

Reich, K. ; Puig, L. ; Szepietowski, J.C....
British Journal of Dermatology.  182 (2019)  2 - p. 304-315 , 2019
 
?
8

Dupilumab treatment improves quality of life in adult patie..:

Tsianakas, A. ; Luger, T.A. ; Radin, A.
British Journal of Dermatology.  178 (2018)  2 - p. e168-e168 , 2018
 
?
10

Dupilumab treatment improves quality of life in adult patie..:

Tsianakas, A. ; Luger, T.A. ; Radin, A.
British Journal of Dermatology.  178 (2018)  2 - p. 406-414 , 2018
 
?
11

Dose‐escalation study evaluating pegylated interferon alpha..:

Schiller, M. ; Tsianakas, A. ; Sterry, W....
Journal of the European Academy of Dermatology and Venereology.  31 (2017)  11 - p. 1841-1847 , 2017
 
?
12

Pruritus bei Psoriasis: Profil und Therapie:

Tsianakas, A. ; Mrowietz, U.
Der Hautarzt.  67 (2016)  8 - p. 601-605 , 2016
 
?
15

Daylight photodynamic therapy with methyl aminolevulinate c..:

Lacour, J‐P. ; Ulrich, C. ; Gilaberte, Y....
Journal of the European Academy of Dermatology and Venereology.  29 (2015)  12 - p. 2342-2348 , 2015
 
1-15